Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Both GcvA and Lrp are required for normal regulation of the
gcv
operon. Moving the GcvA-binding sites 3 and 2 and the Lrp-binding region either closer to, or further away from, the
gcv
promoter by approximately one helical turn of DNA resulted in a less than twofold decrease in glycine-mediated activation or inosine-mediated repression of a gcvT::IacZ fusion. Moving these sites approximately two helical turns of DNA away from the
gcv
promoter resulted in a further loss of both activation and repression; moving these sites approximately three helical turns of DNA from the
gcv
promoter resulted in an essentially complete loss of both glycine-mediated activation and inosine-mediated repression. However, when these sites were moved by approximately 1.5 and 2.5 helical turns of DNA away from the
gcv
promoter, there was a complete loss of both glycine-mediated activation and inosine-mediated repression of the gcvT::IacZ fusion. The flexibility in the absolute distance of the GcvA- and Lrp-binding sites relative to the
gcv
promoter, but strict orientation dependence of these sites is consistent with a possible protein-protein interaction of either GcvA, Lrp, or both of these proteins with
RNA polymerase
. Because of the location of these target sites relative to the
gcv
promoter, it is also likely that DNA looping is required for this mechanism of regulation.
...
PMID:Spacing and orientation requirements of GcvA-binding sites 3 and 2 and the Lrp-binding region for gcvT::lacZ expression in Escherichia coli. 961 15
The Escherichia coli glycine-cleavage enzyme system (gcvTHP and lpd gene products) provides C1 units for cellular methylation reactions. Both the GcvA and leucine-responsive regulatory (Lrp) proteins are required for regulation of the
gcv
operon. One model proposed for
gcv
regulation is that Lrp plays a structural role, bending the DNA to allow GcvA to function as either an activator or a repressor in response to environmental signals. This hypothesis was tested by replacing all but the upstream 22 bp of the Lrp-binding region in a gcvT::lacZ fusion with the I1A site from phage lambda. Integration host factor (IHF) binds the I1A site and bends the DNA about 140 degrees. Shifting the I1A site by increments of 1 base around the DNA helix resulted in IHF-dependent activation and repression of gcvT::lacZ expression that were face-of-the-helix dependent. Activation was also dependent on the GcvA protein, and repression was dependent on both the GcvA and GcvR proteins, demonstrating that the roles for these proteins were not altered. The results are consistent with Lrp playing primarily a structural role in
gcv
regulation, although they do not completely rule out the possibility that Lrp also interacts with another
gcv
-regulatory protein or with
RNA polymerase
.
...
PMID:Role for the leucine-responsive regulatory protein (Lrp) as a structural protein in regulating the Escherichia coli gcvTHP operon. 1021 90